CABERGOLINE (DOSTINEX) (25 MG/TAB. – 10 TAB)

£38.00

+ Free Shipping

Cabergoline works by preventing the production of prolactin. Prolactin is key to a number of processes in the body, especially the female body. Generally, reducing its production can have several benefits.

Because it minimizes the production of prolactin, it helps to suppress the worst side effects of testosterone spiking substances like SARMs, making it a good PCT supplement, like Nolvadex or Clomid (both Selective Estrogen Receptor Modulators).

Category:

Cabergoline (Dostinex) 25 mg/Tablets – 10 Tablets: UK Product Information

Overview

Cabergoline is a dopamine receptor agonist used to reduce excessive prolactin production. It may be prescribed for hyperprolactinaemia and selected disorders involving prolactin regulation.

The stated presentation is 25 mg per tablet with 10 tablets. Because cabergoline tablets are commonly supplied in much lower strengths, the stated specification should be verified against official documentation. The stated strength is not a dosing recommendation.

Appropriate treatment requires medical assessment and professional supervision. Accurate product information is also essential when publishing UK-focused healthcare content for patients and readers.

What Is Cabergoline?

Cabergoline is an ergot-derived dopamine agonist. It primarily stimulates dopamine D2 receptors involved in regulating prolactin secretion from the pituitary gland.

Dostinex is a brand name associated with cabergoline. Online availability does not confirm authenticity, correct labelling, authorisation, or suitability.

Because cabergoline can affect blood pressure, heart function, and the nervous system, treatment should be based on a clear medical indication. It should not be presented as a general hormone-balancing supplement.

25 mg/Tablets – 10 Tablets

The listed specification states 25 mg per tablet and 10 tablets in the package. If accurate, the nominal total quantity would be 250 mg of cabergoline.

However, the stated strength warrants verification because standard cabergoline products are often supplied in strengths such as 0.5 mg per tablet. Product pages should reproduce the strength exactly as shown on legitimate manufacturer or pharmacy documentation.

Package size does not establish how a medicine should be taken.

Medical Uses

Cabergoline is commonly used to treat hyperprolactinaemia, involving abnormally high prolactin levels. Elevated prolactin can contribute to menstrual irregularities, infertility, reduced libido, and inappropriate breast milk production.

The underlying cause of elevated prolactin should be investigated rather than treating laboratory results without appropriate clinical context.

A healthcare professional may assess symptoms, medical history, hormone measurements, pregnancy status where relevant, and before deciding whether treatment is appropriate.

How It Works

Dopamine naturally inhibits prolactin secretion. Cabergoline mimics some of dopamine’s effects by stimulating D2 receptors in the pituitary gland.

This action can reduce prolactin production and help restore hormone levels toward an appropriate range. Clinical response varies between individuals and depends on the underlying condition.

Potential Side Effects

Cabergoline can cause adverse effects. Possible reactions include nausea, headache, dizziness, constipation, fatigue, abdominal discomfort, and low blood pressure, particularly when standing.

Some people may experience sleepiness or other effects involving alertness. Rare but important complications can involve changes affecting heart valves or fibrotic tissues, particularly with prolonged exposure or specific treatment circumstances.

Patients should seek medical advice if they develop persistent breathlessness, chest discomfort, swelling, fainting, or other concerning symptoms. Sudden or severe symptoms require urgent medical assessment.

Interactions and Monitoring

Cabergoline can interact with other medicines. Patients should tell their doctor or pharmacist about prescription medicines, over-the-counter treatments, and supplements they use.

Medicines affecting dopamine pathways may require particular consideration. Blood-pressure-lowering medicines can also increase the possibility of symptomatic hypotension.

Monitoring depends on the indication, treatment duration, dose, and individual risk factors. Clinical reviews and laboratory testing may assess response and safety.

Product Verification

Reliable documentation is essential when evaluating prescription medicines. Relevant details include the active ingredient, exact strength, manufacturer, batch or lot number, expiry date, packaging integrity, storage requirements, and official product information.

Online photographs, reviews, brand names, and promotional descriptions cannot independently establish authenticity. Unregulated products may contain incorrect ingredients, inaccurate strengths, contaminants, or undisclosed substances.

If the stated strength appears unusual or inconsistent with recognised product information, consumers should verify it with a pharmacist or healthcare professional.

UK Regulatory Considerations

UK readers should obtain prescription medicines through legitimate healthcare and pharmacy channels. The Medicines and Healthcare products Regulatory Agency (MHRA) provides regulatory oversight and medicine-safety information in the United Kingdom.

Online availability does not demonstrate that a medicine is authorised, genuine, or suitable for an individual. Responsible UK content should avoid suggesting that prescription cabergoline is an ordinary supplement or appropriate self-treatment for hormone manipulation.

SEO Information for UK Readers

A strong UK-focused page can establish topical relevance through natural terminology rather than repeated commercial wording. Related terms may include cabergoline, Dostinex, dopamine agonist, prolactin treatment, hyperprolactinaemia, pituitary disorders, prescription medicine, tablet strength, medicine safety, UK pharmacy, product verification, and hormone regulation.

Clear headings, accurate specifications, and transparent safety information provide more value than keyword stuffing.

Product Summary

Cabergoline (Dostinex) 25 mg/Tablets – 10 Tablets describes the stated presentation as 25 mg per tablet and 10 tablets per package, representing a nominal 250 mg if the label is accurate. Because this strength appears unusual compared with commonly recognised cabergoline tablet strengths, verification from authoritative product documentation is especially important.

It does not establish medical suitability, authenticity, effectiveness, or a safe personal regimen.

This page provides factual medical and regulatory information only. It does not recommend self-administration, provide personalised dosing instructions, or encourage non-prescribed use.

UK readers seeking treatment for elevated prolactin or related symptoms should consult a qualified doctor, endocrinologist, or pharmacist. Professional assessment can help identify the underlying cause, confirm the correct medicine and strength, review interactions, and establish appropriate monitoring.

Reviews

There are no reviews yet.

Be the first to review “CABERGOLINE (DOSTINEX) (25 MG/TAB. – 10 TAB)”

Your email address will not be published. Required fields are marked *

Shopping Cart